Prevalence of Alzheimer’s disease (AD) dementia and mild cognitive impairment (MCI) in the United States Medicare population

Haixin Zhang,Quanwu Zhang,Amir Abbas Tahami Monfared

DOI: https://doi.org/10.1002/alz.077079

2023-12-01

Abstract:Abstract Background Alzheimer’s disease (AD) is a chronic, neurodegenerative health condition. Mild cognitive impairment (MCI) is characterized by cognitive decline, without dementia. We aimed to estimate the prevalence of AD and MCI among Medicare beneficiaries. Method Patients were identified from the US Center for Medicare and Medicaid Services (CMS) database using International Classification of Diseases (ICD) codes for AD (331.0, G30.9, G30.8, or G30.1,) and MCI (331.83 or G31.84). Both AD and MCI were identified using the search rule of 2 ICD codes ≥30 days apart ≤365 days from both Medicare fee‐for‐service (FFS: 2008‐2018) and Medicare Advantage (MA: 2015‐2018). US regions were derived using zip codes and categorized by National Center for Chronic Disease Prevention/Health Promotion regions. Yearly prevalence was defined as the number of cases of AD or MCI in each year divided by the Medicare population in the year. Confidence intervals were not reported due to small intervals. Result The prevalence of AD and MCI was 1.9% and 0.1% (2008), 2.5 and 0.2% (2009), 2.7 and 0.2% (2010), 2.7 and 0.3% (2011), 2.8 and 0.4% (2012), 2.8 and 0.5% (2013), 2.8 and 0.6% (2014), 2.8 and 0.7% (2015), 2.3 and 0.7% (2016), 2.4 and 0.9% (2017), and 2.3 and 1% (2018), respectively. About 1.2 million AD patients and 490,000 MCI patients were identified in 2018. The prevalence of AD vs MCI among demographic subgroups in 2018 was 1.81% vs 0.85% (men) and 2.75% vs 1.03% (women); 0.59% vs 0.35% (ages 65‐69 years), 1.16% vs 0.65% (70‐74 years), 2.45% vs 1.19% (75‐79 years), 4.56% vs 1.86% (80‐84 years), and 8.71% vs 2.67% (≥85 years); 2.46% vs 1.05% (Whites), 1.87% vs 0.54% (Blacks), and 2.18% vs 0.58% (Asians). The prevalence of AD vs MCI in 2018 was highest in the US Northeast, especially in New Hampshire (3.25% vs 1.64%), Maryland (3.23% vs 1.45%) and New Jersey (3.43% vs 1.40%). Conclusion Among Medicare beneficiaries from 2008 to 2018, AD prevalence was generally stable, while MCI increased. Women, older age, White race, and Northeast region were associated with higher prevalence of AD and MCI in 2018.

clinical neurology